| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |